Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Nov 20, 2019 | TCTMD

LONDON, England—Follow-up data from the PORTICO I study testing the self-expanding Portico transcatheter heart valve (Abbott) show a low rate of cardiovascular mortality and disabling stroke at 2 years, as well as continued low transvalvular gradients and large valve areas.